PARSIPPANY, N.J., Feb. 25 /PRNewswire-FirstCall/ -- PDI, Inc. (NASDAQ: PDII), a leading provider of sales and marketing support to U.S. health care companies, today announced that it will...
PARSIPPANY, N.J., Feb. 2 /PRNewswire-FirstCall/ -- PDI, Inc. (NASDAQ: PDII), a leading provider of sales and marketing support to U.S. health care companies, today announced that Chief Executive...
PARSIPPANY, N.J., Jan. 14 /PRNewswire-FirstCall/ -- PDI, Inc. (NASDAQ: PDII) today announced that Board of Directors member Joseph T. Curti, M.D. died on January 12, 2010 at the age of 71. Dr...
In less than three weeks, company has announced two new and significant business wins and a major existing-contract renewal PARSIPPANY, N.J., Jan. 11 /PRNewswire-FirstCall/ -- PDI, Inc. (NASDAQ:...
Second consecutive year that engagement contract has been extended by Top 5 pharma client PARSIPPANY, N.J., Jan. 7 /PRNewswire-FirstCall/ -- PDI, Inc. (NASDAQ: PDII), a leading provider of sales...
PARSIPPANY, N.J., Dec. 23 /PRNewswire-FirstCall/ -- PDI, Inc. (NASDAQ: PDII), a leading provider of sales and marketing support to U.S. health care companies, has been awarded a significant...
Management will host Conference Call at 4:30 PM ET Today SADDLE RIVER, N.J., Nov. 5 /PRNewswire-FirstCall/ -- PDI, Inc. (NASDAQ: PDII), a leading provider of sales and marketing support to U.S...
New solutions will improve the ability of life sciences companies to service their clinician customers via a convenient, optimized network of integrated personal, online and mobile channels...
SADDLE RIVER, N.J., Oct. 29 /PRNewswire-FirstCall/ -- PDI, Inc. (NASDAQ: PDII), a leading provider of sales and marketing support to U.S. pharmaceutical companies, today announced that it will...
Management will host Conference Call at 4:30 PM ET Today SADDLE RIVER, N.J., Aug. 5 /PRNewswire-FirstCall/ -- PDI, Inc. (NASDAQ: PDII), a leading provider of sales and marketing support to U.S...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales